Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN |
C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis | Phase3 |
Argentina Brazil China France Germany Greece Israel Italy Japan Netherlands Spain Switzerland Turkey (Türkiye) United Kingdom United States View All
|
NCT03955445 |
|
Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation |
Hidradenitis Suppurativa | France | NCT06444087 | |
|
Regulatory Post-Marketing Surveillance Study for Brolucizumab |
Neovascular Age-related Macular Degeneration | South Korea | NCT04985487 | |
|
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea |
Graft-versus-Host Disease | South Korea | NCT05621733 | |
|
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function |
Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase2 |
France Germany Italy Spain United States View All
|
NCT06004661 |
|
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase2 |
Burkina Faso Côte d’Ivoire Gabon Ghana Kenya Uganda View All
|
NCT05750628 |
|
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC |
Prostatic Neoplasm | Phase2 |
Brazil Canada China Czechia France Germany Italy Netherlands Poland Singapore South Korea Spain United States View All
|
NCT05849298 |
|
A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN) |
Lupus Erythematosus, Systemic, Lupus Nephritis | Phase2 |
Australia Austria Czechia Denmark France Germany Italy Japan Netherlands Norway Romania Singapore South Korea Spain Switzerland Taiwan United Kingdom United States View All
|
NCT06581198 |
|
Secukinumab Open Label Roll-over Extension Protocol |
Autoimmunity, Inflammation | Phase4 |
Brazil Bulgaria China Colombia Czechia Guatemala Italy Poland Portugal Russia South Africa Spain Switzerland United States View All
|
NCT04638647 |
|
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT |
Prostate Cancer | Phase1, Phase2 |
Australia Canada France United States View All
|
NCT05983198 |